Ovarian Cancer Research Alliance (@ocrahope) header
Ovarian Cancer Research Alliance (@ocrahope) profile picture

OCRA is the largest non-profit organization in the world combating ovarian and all gynecologic cancers.

DC and NYC
Joined January 2016
Recent research points to a molecular link between ovarian aging and cancer. Findings from @NorthwesternU and @BuckInstitute could inform future studies into whether targeting the aging ovary therapeutically may lower ovarian cancer risk. #GynCSM #OvarianCancer news.northwestern.edu/storie…
35
Gynecologic cancers impact patients and their loved ones in many ways, with work, finances, and insurance all potentially affected. Join our partner @TriageCancer for a free online conference focused on strategies to navigate these legal and practical challenges. Register today: TriageCancer.org/Conferences #TriageTalks #GynCSM
47
Addressing practical matters in advance can help reduce stress when navigating a gynecologic cancer diagnosis. OCRA is offering a free online workshop focused on tools to prepare for future needs, including advance directives and disability insurance. Register: bit.ly/4iwknSF
1
54
Supporting a loved one through a gynecologic cancer diagnosis can bring new challenges. OCRA is here with resources for caregivers: bit.ly/4zp7scq #NationalFamilyCaregiversMonth #GynCSM
2
92
OCRA’s Advocate Leaders program is on track to have its biggest cohort yet. Plus, highlights from the 16th Biennial Rivkin Ovarian Cancer Research Symposium, a message of thanks to our community, resources for caregivers, and more. Get details at bit.ly/4zow7xP
1
109
Informed choices that align with patients’ personal goals can make all the difference when it comes to care. OCRA is offering a free series open to patients, survivors & loved ones, with the first session focused on determining care goals: bit.ly/4zlfKCk
2
77
Thanks to the generosity of all who give to OCRA, we can continue to offer support, advance research, and advocate for our community. Visit bit.ly/4f02Gda to learn about the many ways to donate, such as giving through stocks or IRAs.
1
1
77
Clear, current information is a crucial resource when navigating a diagnosis. An updated guide about ovarian cancer offered by the National Comprehensive Cancer Network (@NCCN) & proudly sponsored by OCRA is now available: bit.ly/4kkueNV
1
87
OCRA welcomed the opportunity to connect with attendees at the Race to End Women’s Cancer last month in Washington, DC, where we raised awareness about ovarian & gynecologic cancers. Thank you to our volunteers, all who stopped by our table, and the Foundation for Women’s Cancer for bringing so many of us together in support of our shared cause. @GYNCancer @ChemoBabe1
83
OCRA is thrilled to have brought together more than 375 ovarian cancer researchers, clinicians, and advocates to share findings at the 16th Biennial Rivkin Ovarian Cancer Research Symposium in Philadelphia: bit.ly/48dNKo3. Sessions explored a wide range of topics, including immuno-oncology, prevention and early detection, and rare subtypes. Thank you to all who attended! OCRA is grateful to the sponsors who made the Symposium possible, including Presenting Scientific Sponsor @AbbVie; Advocate Sponsors @AstraZeneca, Corcept Therapeutics, and @Genmab; and Contributor Sponsor @GSK. @Ronny_Drapkin @SophiaHLGe @GillianEHanley
1
8
165
Research advances are changing how biomarker tests are used to personalize gynecologic cancer care. Sarah Ackroyd, MD, MPH, of @UChicago, will discuss biomarkers and their role in treatment during OCRA’s free webinar on Oct. 28. Register: bit.ly/4Bp9SJt @SarahAckroydMD @UChicagoMed @UCCancerCenter
4
4
221
More than 700 people have joined the Living Lab. What does that actually mean for research? Living Lab Principal Investigator Leigh Pearce explains what’s already possible and what becomes possible as the registry grows: bit.ly/4dUlNoG
3
133
Have you or a loved one been diagnosed with FATWO (female adnexal tumor of Wolffian origin)? Connect with others who share this rare diagnosis during a special online meetup on Oct. 22 at 12:30 pm ET. For more information and the meeting link, contact [email protected]
94
Get details about an early study showing that a blood test combining platelet RNA with routine blood-count data detected ovarian cancer more accurately than CA-125; an analysis involving 91,000 patients demonstrating that robotic and laparoscopic hysterectomy provide similar survival outcomes for endometrial cancer; and other findings. Learn more at bit.ly/480cjVp
2
2
110
Join OCRA for an interactive online roundtable offering a supportive space for patients & survivors who have faced both a breast and gynecologic cancer diagnosis. Register: bit.ly/4zDqI5F
1
75
Cancer-fighting T cells mass-produced from blood stem cells and engineered to target a protein known as NY-ESO-1 show promise for treating ovarian cancer and other solid tumors. Developed by UCLA researchers, this method may offer an alternative to the costly and lengthy process currently used, which requires each patient’s own T cells. @DGSoMUCLA @MicrobioUCLA @UCLAHealthJCCC uclahealth.org/news/release/…
1
2
126
Leaders in ovarian cancer research and treatment are coming together in Philadelphia for the 16th Biennial Rivkin Ovarian Cancer Research Symposium, now presented by OCRA. As we get ready to delve into the latest discoveries in the field, OCRA wants to take a moment to acknowledge the following sponsors for their support of the Symposium: Presenting Scientific Sponsor @AbbVie; Advocate Sponsors @AstraZeneca, Corcept Therapeutics, and @Genmab; and Contributor Sponsor @GSK. Thank you!
1
2
121
Our final answer is… gratitude! Thank you, Jackie Tohn, for donating your winnings from “Who Wants To Be A Millionaire” to OCRA. And many congrats on a game well played alongside your teammate and “Nobody Wants This” co-star Timothy Simons: bit.ly/3U1Rh5n. @JackieTohn @TimothyCSimons @JimmyKimmel @MillionaireTV @ABCNetwork @Hulu @Disney @NWTNetflix #WhoWantsToBeAMillionaire
1
143